| 000 | 01671cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 130224s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.10.M.Sc.2012.Mi.A | ||
| 100 | 0 | _aMiranda Nabil Wasfy Tawfik | |
| 245 | 1 | 4 |
_aThe association between psoriasis and metabolic syndrome : _bA case control study / _cMiranda Nabil Wasfy Tawfik ; Supervised Naglaa Nabil Elmongy , Nermine Hamdi Eleishi , Rehab Mohamed Sobhi |
| 246 | 1 | 5 | _aدراسة العلاقة بين الصدفية ومتلازمة |
| 260 |
_aCairo : _bMiranda Nabil Wasfy Tawfik , _c2012 |
||
| 300 |
_a117P. : _bcharts , facsimils ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology | ||
| 520 | _aBackground : Psoriasis has been established to be a systemic disease centered on inflammation and involvement of cytokines of the type 1 helper T cell (Th1) pathway . Psoriasis patients have an increased prevalence of the core components of metabolic syndrome . The novel discovery of the systemic role of vitamin D in the modulation of the immune system especially the Th1 pathway reveals its potential for treating Th1 inflammatory diseases | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aMetabolic syndrome | |
| 653 | 4 | _aPsoriasis | |
| 653 | 4 | _aVitamin D | |
| 700 | 0 |
_aNaglaa Nabil Elmongy , _eSupervisor |
|
| 700 | 0 |
_aNermine Hamdi Eleishi , _eSupervisor |
|
| 700 | 0 |
_aRehab Mohamed Sobhi , _eSupervisor |
|
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41698 _d41698 |
||